PD-L1 Antibody
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients (NCT07142863) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2025-08-25 |
Track PD-L1 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.